US OptionsDetailed Quotes
RIGL241220C25000
- 0.13
- 0.000.00%
15min DelayClose Dec 13 16:00 ET
0.00High0.00Low
0.13Open0.13Pre Close0 Volume2 Open Interest25.00Strike Price0.00Turnover169.14%IV32.89%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.13Extrinsic Value100Contract SizeAmericanOptions Type0.0850Delta0.0433Gamma145.46Leverage Ratio-0.0564Theta0.0002Rho12.37Eff Leverage0.0033Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet